发布求助
文献互助 智能选刊 最新文献

European Oncology and Haematology最新文献

筛选
英文 中文
Isochromosome i(7)(q10) in Myelodysplastic Syndrome – Case Report 骨髓增生异常综合征的同染色体i(7)(q10) -病例报告
European Oncology and Haematology Pub Date : 2019-01-01 DOI: 10.17925/eoh.2019.15.2.102
Yhasmine Delles Oliverira Garcia, Juliene Lima Mesquita, Y. Z. Rosales, T. Santos, A. G. Moura, João Vitor Araújo Duarte, Beatrice Araújo Duarte, E. Velloso, F. D. R. Filho, F. Duarte, R. Lemes
{"title":"Isochromosome i(7)(q10) in Myelodysplastic Syndrome – Case Report","authors":"Yhasmine Delles Oliverira Garcia, Juliene Lima Mesquita, Y. Z. Rosales, T. Santos, A. G. Moura, João Vitor Araújo Duarte, Beatrice Araújo Duarte, E. Velloso, F. D. R. Filho, F. Duarte, R. Lemes","doi":"10.17925/eoh.2019.15.2.102","DOIUrl":"https://doi.org/10.17925/eoh.2019.15.2.102","url":null,"abstract":"<p />","PeriodicalId":38554,"journal":{"name":"European Oncology and Haematology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67593133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cancer Nursing Deserves Better Recognition 癌症护理应该得到更好的认可
European Oncology and Haematology Pub Date : 2019-01-01 DOI: 10.17925/eoh.2019.15.1.19
D. Kelly
{"title":"Cancer Nursing Deserves Better Recognition","authors":"D. Kelly","doi":"10.17925/eoh.2019.15.1.19","DOIUrl":"https://doi.org/10.17925/eoh.2019.15.1.19","url":null,"abstract":"<p />","PeriodicalId":38554,"journal":{"name":"European Oncology and Haematology","volume":"190 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67593030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting Tyrosine-protein Kinase Receptor (MET) Gene Alterations in Non-small Cell Lung Cancer – The Efficacy and Safety of Tepotinib + Gefitinib in the INSIGHT Study 靶向酪氨酸蛋白激酶受体(MET)基因改变在非小细胞肺癌中的疗效和安全性-在INSIGHT研究中替波替尼+吉非替尼
European Oncology and Haematology Pub Date : 2019-01-01 DOI: 10.17925/eoh.2019.15.2.86
Y. Wu
{"title":"Targeting Tyrosine-protein Kinase Receptor (MET) Gene Alterations in Non-small Cell Lung Cancer – The Efficacy and Safety of Tepotinib + Gefitinib in the INSIGHT Study","authors":"Y. Wu","doi":"10.17925/eoh.2019.15.2.86","DOIUrl":"https://doi.org/10.17925/eoh.2019.15.2.86","url":null,"abstract":"<p />","PeriodicalId":38554,"journal":{"name":"European Oncology and Haematology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67592728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gaucher Disease for the Haematologist 戈谢病的血液科医生
European Oncology and Haematology Pub Date : 2019-01-01 DOI: 10.17925/eoh.2019.15.1.14
M. Cappellini
{"title":"Gaucher Disease for the Haematologist","authors":"M. Cappellini","doi":"10.17925/eoh.2019.15.1.14","DOIUrl":"https://doi.org/10.17925/eoh.2019.15.1.14","url":null,"abstract":"<p />","PeriodicalId":38554,"journal":{"name":"European Oncology and Haematology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67592984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment Sequencing of Abiraterone Acetate plus Prednisone and Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer 醋酸阿比特龙联合强的松和恩杂鲁胺治疗转移性去势抵抗性前列腺癌的治疗顺序
European Oncology and Haematology Pub Date : 2019-01-01 DOI: 10.17925/eoh.2019.15.2.1
B. Maughan, J. Gschwend
{"title":"Treatment Sequencing of Abiraterone Acetate plus Prednisone and Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer","authors":"B. Maughan, J. Gschwend","doi":"10.17925/eoh.2019.15.2.1","DOIUrl":"https://doi.org/10.17925/eoh.2019.15.2.1","url":null,"abstract":"<p />","PeriodicalId":38554,"journal":{"name":"European Oncology and Haematology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67593095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Treatment of Hodgkin Lymphoma – New and Developing Therapies and Their Potential Role in Standard of Care 霍奇金淋巴瘤的治疗-新的和发展中的治疗方法及其在标准治疗中的潜在作用
European Oncology and Haematology Pub Date : 2019-01-01 DOI: 10.17925/eoh.2019.15.1.53
T. Vassilakopoulos, B. Böll
{"title":"Treatment of Hodgkin Lymphoma – New and Developing Therapies and Their Potential Role in Standard of Care","authors":"T. Vassilakopoulos, B. Böll","doi":"10.17925/eoh.2019.15.1.53","DOIUrl":"https://doi.org/10.17925/eoh.2019.15.1.53","url":null,"abstract":"Hodgkin lymphoma is a B-cell lymphoma that currently has a cure rate of ≥85% in patients with early-stage disease, using first-line chemotherapy followed by involved field radiotherapy. However, an unmet need remains in those with advanced and relapsed/ refractory Hodgkin lymphoma. In this review, we provide an overview of new and developing agents and discuss how these may re-shape clinical care strategies for patients with Hodgkin lymphoma. Overall, the emergence of targeted therapies such as brentuximab vedotin and immunotherapies such as nivolumab or pembrolizumab, provide new and exciting treatment options for patients. It is hoped that these will form single-agent and combination strategies that will re-shape the therapeutic landscape in Hodgkin lymphoma by (i) replacing elements of standard chemotherapy in low-risk patients to reduce toxicity and long-term complications, and (ii) by integrating into standardof-care therapies for advanced, high-risk or relapsed patients. Currently, brentuximab vedotin provides more robust and mature phase III clinical data in Hodgkin lymphoma, based on which, it appears reasonable to predict that brentuximab vedotin will form part of the first-line therapy for advanced Hodgkin lymphoma.","PeriodicalId":38554,"journal":{"name":"European Oncology and Haematology","volume":"287 1","pages":"53"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72749184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Chimeric Antigen Receptor T-cell Therapy for Relapsed or Refractory Large B-cell Lymphoma – Latest Data from the ZUMA-1 Study 嵌合抗原受体t细胞治疗复发或难治性大b细胞淋巴瘤-来自ZUMA-1研究的最新数据
European Oncology and Haematology Pub Date : 2019-01-01 DOI: 10.17925/eoh.2019.15.1.16
J. Muñoz
{"title":"Chimeric Antigen Receptor T-cell Therapy for Relapsed or Refractory Large B-cell Lymphoma – Latest Data from the ZUMA-1 Study","authors":"J. Muñoz","doi":"10.17925/eoh.2019.15.1.16","DOIUrl":"https://doi.org/10.17925/eoh.2019.15.1.16","url":null,"abstract":"<p />","PeriodicalId":38554,"journal":{"name":"European Oncology and Haematology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67593021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Technical Challenges in the Manufacture of Dendritic Cell Cancer Therapies 树突状细胞癌症治疗制造中的技术挑战
European Oncology and Haematology Pub Date : 2019-01-01 DOI: 10.17925/eoh.2019.15.1.22
M. Lozano, J. Cid, D. Benítez-Ribas, M. Otero
{"title":"Technical Challenges in the Manufacture of Dendritic Cell Cancer Therapies","authors":"M. Lozano, J. Cid, D. Benítez-Ribas, M. Otero","doi":"10.17925/eoh.2019.15.1.22","DOIUrl":"https://doi.org/10.17925/eoh.2019.15.1.22","url":null,"abstract":"<p />","PeriodicalId":38554,"journal":{"name":"European Oncology and Haematology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67593037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of New Immunophenotypic Markers on Prognostic and Overall Survival of Acute Lymphoblastic Leukaemia – A Systematic Review and Meta-analysis 新的免疫表型标志物在急性淋巴细胞白血病预后和总生存中的作用——一项系统回顾和荟萃分析
European Oncology and Haematology Pub Date : 2019-01-01 DOI: 10.17925/eoh.2019.15.2.113
Wesley Messias Santos, A. F. Costa, L. H. S. Pinheiro, N. L. Silva, A. Sandes, M. A. Nunes, C. Corrêa, Carlos Arthur Cardoso Almeida, G.M.S. Cruz, D. L. Junior, D. M. Schimieguel
{"title":"Role of New Immunophenotypic Markers on Prognostic and Overall Survival of Acute Lymphoblastic Leukaemia – A Systematic Review and Meta-analysis","authors":"Wesley Messias Santos, A. F. Costa, L. H. S. Pinheiro, N. L. Silva, A. Sandes, M. A. Nunes, C. Corrêa, Carlos Arthur Cardoso Almeida, G.M.S. Cruz, D. L. Junior, D. M. Schimieguel","doi":"10.17925/eoh.2019.15.2.113","DOIUrl":"https://doi.org/10.17925/eoh.2019.15.2.113","url":null,"abstract":"<p />","PeriodicalId":38554,"journal":{"name":"European Oncology and Haematology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67593174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Midostaurin for FLT3-mutated Acute Myeloid Leukaemia – Considerations for Optimal Use 米多斯汀治疗flt3突变的急性髓性白血病-最佳使用考虑
European Oncology and Haematology Pub Date : 2019-01-01 DOI: 10.17925/eoh.2019.15.1.43
G. Ossenkoppele
{"title":"Midostaurin for FLT3-mutated Acute Myeloid Leukaemia – Considerations for Optimal Use","authors":"G. Ossenkoppele","doi":"10.17925/eoh.2019.15.1.43","DOIUrl":"https://doi.org/10.17925/eoh.2019.15.1.43","url":null,"abstract":"<p />","PeriodicalId":38554,"journal":{"name":"European Oncology and Haematology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67593082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信